Disclosures for "Developing NF1-specific Brain Growth Charts from Clinical Brain MRIs: A Framework for Classifying Image Pathology and Suitability for Quantitative Image Processing"
-
Mr. Akouri has nothing to disclose.
-
Dr. Mandal has nothing to disclose.
-
Mr. Writer has nothing to disclose.
-
Mr. Buczek has nothing to disclose.
-
Dr. Sotardi has nothing to disclose.
-
Dr. Vossough has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Vossough has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DeepSight. Dr. Vossough has received publishing royalties from a publication relating to health care.
-
Mr. Padmanabhan has nothing to disclose.
-
Mr. Williams has nothing to disclose.
-
Dr. Ball has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. The institution of Dr. Ball has received research support from NHMRC.
-
Prof. Payne has nothing to disclose.
-
Dr. North has nothing to disclose.
-
Dr. Muhlert has nothing to disclose.
-
The institution of Dr. Garg has received research support from US Department of Defence.
-
Dr. Seidlitz has stock in Centile Bioscience.
-
Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks. The institution of Dr. Fisher has received research support from AstraZeneca/Alexion. The institution of Dr. Fisher has received research support from Array BioPharma.
-
Mr. Alexander-Bloch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Mr. Alexander-Bloch has stock in Centile Bioscience. The institution of Mr. Alexander-Bloch has received research support from NIH. The institution of Mr. Alexander-Bloch has received research support from DOD. Mr. Alexander-Bloch has received intellectual property interests from a discovery or technology relating to health care. Mr. Alexander-Bloch has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with NIH.